Case report of a novel mutation in the TNC gene in Chinese patients with nonsyndromic hearing loss

Author:

Li Shouxia1,Li Shurui1,Chen Dingli1,Zhao Subin2,Liu Cairu3,Zhang Ruimin4,Chen Yongxue5,Guo Xiangrui6,Song Xuedong1ORCID

Affiliation:

1. Department of Laboratory Medicine, Handan Central Hospital, Hebei Medical University, Handan, Hebei, China

2. Department of General Surgery, Affiliated Hospital of Hebei University of Engineering, Handan, Hebei, China

3. Department of Obstetrics, Handan Central Hospital, Hebei Medical University, Handan, Hebei, China

4. Department of Neonatology, Handan Central Hospital, Hebei Medical University, Handan, Hebei, China

5. Department of Anesthesiology, Handan Central Hospital, Hebei Medical University, Handan, Hebei, China

6. Department of Laboratory Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.

Abstract

Rationale: Hereditary hearing loss is known to exhibit a significant degree of genetic heterogeneity. Herein, we present a case report of a novel mutation in the tenascin-C (TNC) gene in Chinese patients with nonsyndromic hearing loss (NSHL). Patient concerns: This includes a young deaf couple and their 2-year-old baby. Diagnoses: Based on the clinical information, hearing test, metagenomic next-generation sequencing (mNGS), Sanger sequencing, protein function and structure analysis, and model prediction, in our case, the study results revealed 2 heterozygous mutations in the TNC gene (c.2852C>T, p.Thr951Ile) and the TBC1 domain family member 24 (TBC1D24) gene (c.1570C>T, p.Arg524Trp). These mutations may be responsible for the hearing loss observed in this family. Notably, the heterozygous mutations in the TNC gene (c.2852C>T, p.Thr951Ile) have not been previously reported in the literature. Interventions: Avoid taking drugs that can cause deafness, wearing hearing AIDS, and cochlear implants. Outcomes: Regular follow-up of family members is ongoing. Lessons: The genetic diagnosis of NSHL holds significant importance as it helps in making informed treatment decisions, providing prognostic information, and offering genetic counseling for the patient’s family.

Publisher

Ovid Technologies (Wolters Kluwer Health)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3